Comparison

CX-5461 European Partner

Item no. HY-13323-200mg
Manufacturer MedChem Express
CASRN 1138549-36-6
Amount 200 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Specific against other
Purity 99.49
Smiles CC1=NC=C(CNC(C2=C3N(C4=NC(N5CCN(CCC5)C)=CC=C4C2=O)C6=C(S3)C=CC=C6)=O)N=C1
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
DNA/RNA Synthesis
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
513.61
Product Description
CX-5461 is a potent and oral rRNA synthesis inhibitor. It inhibits RNA polymerase I-driven transcription of rRNA with IC50s of 142, 113, and 54 nM in HCT-116, A375, and MIA PaCa-2 cells, respectively[1].
Manufacturer - Research Area
Cancer
Solubility
50 mM Sodium phosphate (pH 3.5) : 10 mg/mL (ultrasonic)|DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C)|H2O : 55.56 mg/mL (ultrasonic; adjust pH to 2 with HCl)
Manufacturer - Pathway
Cell Cycle/DNA Damage
Clinical information
Phase 1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?